Clinical trial Recruiting at 1 site Interventional Ages 19 to 40 Women only

Compare two norepinephrine doses to prevent low blood pressure after spinal anesthesia for C-section

Official title: The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section

Run by Assiut University · NCT06102382 · Data updated 2026-11-12

This study will see if two different infusion rates of norepinephrine can prevent low blood pressure in women having a planned cesarean delivery with spinal anesthesia.

Quick facts

Study typeInterventional
Ages19 Years to 40 Years
SexWomen only
Enrollment100 (estimated)
SponsorAssiut University
Academic / other
Locations1 site (Asyut)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedOctober 1, 2025
Study endsDecember 1, 2025
Registry record updatedAugust 29, 2025
Trial IDNCT06102382 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women at term (≥37 weeks) scheduled for elective cesarean under spinal anesthesia who do not have cardiac disease, hypertensive disorders of pregnancy, severe obesity, or contraindications to spinal anesthesia.

Probably not a fit

Women with cardiac morbidities, hypertensive pregnancy disorders, severe obesity (BMI ≥40), significant prepartum hemorrhage, or those who decline spinal anesthesia would not be candidates and are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center interventional study compares two prophylactic norepinephrine infusion rates given around the time of spinal anesthesia for planned cesarean delivery. Eligible term pregnant women without major cardiac disease, hypertensive disorders, severe obesity, or contraindications to spinal anesthesia will receive one of the two norepinephrine regimens during the operation. Maternal blood pressure, need for rescue vasopressors, and common side effects such as nausea, bradycardia, or hypertension will be recorded and compared between groups. The goal is to identify which infusion rate better prevents post-spinal hypotension with acceptable safety.

Why it matters

Potential benefit: If successful, the preferred norepinephrine dose could reduce episodes of maternal low blood pressure during cesarean delivery and decrease the need for rescue medications and associated symptoms.

How similar studies have gone: Previous small studies and clinical reports have shown promising results with norepinephrine for preventing post-spinal hypotension, but the optimal prophylactic dose has not been established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women scheduled for cesarean section under spinal anesthesia
* Gestational age of at least 37 weeks

Exclusion Criteria:

* Patient refusal
* Contraindications of spinal anesthesia
* Allergy to the study drug
* Height\<150 cm, weight \< 60 kg, body mass index (BMI) ≥40 kg/m2.
* patients with cardiac morbidities
* Hypertensive disorders of pregnancy.
* Prepartum hemorrhage

Where it's running

  • Assiut University Woman Health Hospital
    Asyut, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.